Quest Diagnostics Incorporated Press Releases

DGX 
$67.78
*  
0.16
0.24%
Get DGX Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading DGX now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
FDA Clears the Focus Diagnostics Simplexa™ Flu A/B & RSV Direct Test to Include Eight Circulating Influenza Viruses
12/9/2014 9:21:00 AM - PR Newswire
▲4.12 % Price Change since this news event. The Volume Ratio is 0.7.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Quest Diagnostics Declares Quarterly Cash Dividend
12/4/2014 1:15:00 PM - PR Newswire
▲4.70 % Price Change since this news event. The Volume Ratio is 3.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Quest Diagnostics To Speak At The Piper Jaffray 26th Annual Healthcare Conference
12/1/2014 11:18:00 AM - PR Newswire
▲4.89 % Price Change since this news event. The Volume Ratio is 0.81.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


OPTIMIZERx Corp. to Automate Patient Savings and Improve Medication Adherence for Patients Served by Providers Utilizing Care360 ePrescribing From Quest Diagnostics
11/17/2014 7:05:00 AM - Market Wire


Quest Diagnostics Discusses Progress in Executing Strategy to Drive Shareholder Value and Presents Outlook at Investor Day
11/5/2014 8:00:00 AM - PR Newswire
▲10.41 % Price Change since this news event. The Volume Ratio is 1.45.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Quest Diagnostics Introduces BRCAvantage Plus™, Providing New Choices in Genetic Breast Cancer Risk Testing
11/4/2014 12:50:00 PM - PR Newswire
▲12.95 % Price Change since this news event. The Volume Ratio is 3.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Quest Diagnostics Reports Third Quarter 2014 Financial Results
10/23/2014 7:00:00 AM - PR Newswire
▲10.73 % Price Change since this news event. The Volume Ratio is 1.58.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
10/22/2014 8:44:00 AM - PR Newswire
▲10.90 % Price Change since this news event. The Volume Ratio is 2.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Quest Diagnostics To Release Third Quarter 2014 Financial Results On October 23
10/7/2014 4:59:00 PM - PR Newswire


Quest Diagnostics Unveils New State-of-the-Art Clinical Laboratory in Marlborough, Massachusetts
10/2/2014 9:28:00 AM - PR Newswire


Siemens, Inpeco and Quest Diagnostics Join Forces to Build the Lab of the Future
10/2/2014 9:00:00 AM - Business Wire


Quest Diagnostics To Host Investor Day On November 5, 2014
10/1/2014 4:50:00 PM - PR Newswire


Quest Diagnostics Names Mayo Clinic Executive Franklin R. Cockerill, M.D., Vice President and Chief Laboratory Officer
10/1/2014 8:48:00 AM - PR Newswire